Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomal-associated membrane protein 1 (LAMP1), also known as lysosome-associated membrane glycoprotein 1 and CD107a, is a type I transmembrane glycoprotein and a major component of the lysosomal membrane. It regulates lysosome biogenesis and autophagy, maintains lysosomal pH homeostasis, and participates in cholesterol homeostasis. It is also a degranulation marker on cytotoxic lymphocytes. Altered expression or dysfunction has been linked to various diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal-associated membrane protein 1 (LAMP1).